“The Past, Present, and Future of STK11 Mutations In Non-Small Cell Lung Carcinoma”

At the conclusion of this activity, the participant will be able to:

1. Discuss the impacts of advancing molecular diagnostics on non-small cell lung carcinoma

2. Identify the role of STK11 gene mutations in the setting of non-small cell lung carcinoma

3. Assess the role of targeted therapies for non-small cell lung carcinoma as our understanding of mutational profiles expands

plate with fork and knife, books, microscope and test tubes
Sponsor(s)
Medicine: Pathology
Speaker(s)
Patrick Memari, DO, Cytopathology Fellow, Department of Pathology, Virginia Commonwealth University, School of Medicine
Audience
Administration , VCU Alumni, VCU Faculty, VCU Health Care Providers, VCU Physicians, VCU Staff, School of Medicine